Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of DA-6034 with a non-inferiority aim for acute and chronic gastritis. The trial status is listed as U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• DA-6034

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Acute Gastritis, Chronic Gastritis | Phase 3 | Status: UNKNOWN